Increased Levels of Asymmetric Dimethylarginine and C-Reactive Protein are Associated with Impaired Vascular Reactivity in Essential Hypertension

Abstract

Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase and has been implicated in endothelial dysfunction. We sought to assess weather inflammation is involved in the impaired vascular reactivity induced by ADMA in essential hypertension. Brachial artery flow-mediated dilation (FMD), serum ADMA, and C-reactive protein were determined in 71 never-treated hypertensive patients. Serum ADMA was related directly to C-reactive protein and reversely to FMD. In multiple regression analysis, ADMA was the only independent determinant of FMD. Probably, the chronic inflammation documented in these patients may be considered the mechanistic link between ADMA and vascular damage.

Keywords:

• asymmetric dimethylarginine
• C-reactive protein
• flow-mediated dilation
• essential hypertension
• inflammation

Acknowledgments

This study is supported by the Key Science and Technology Program of Heilongjiang Province, China (WB08B09). The authors thank Jun Wang for his excellent technical assistance on the ADMA assay.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.